Concepedia

Publication | Open Access

Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis

DOIFull Paper Access

274

Citations

33

References

2013

Year

Rohit Aggarwal, Andriy I. Bandos, Ann M. Reed, Dana P. Ascherman, Richard J. Barohn, Brian M. Feldman, Frederick W. Miller, Lisa G. Rider, Michael O. Harris‐Love, Marc C. Levesque
Arthritis & Rheumatology

Abstract

Our findings indicate that the presence of antisynthetase and anti-Mi-2 autoantibodies, juvenile DM subset, and lower disease damage strongly predict clinical improvement in patients with refractory myositis.

References

YearCitations

Page 1